{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:07:55Z","timestamp":1792876075809,"version":"4.5.0"},"reference-count":144,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Napp Pharmaceuticals Limited"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Fungal diseases represent a considerable global health concern, affecting &amp;gt;1 billion people annually. In response to this growing challenge, the World Health Organization introduced the pivotal fungal priority pathogens list (FPPL) in late 2022. The FPPL highlights the challenges in estimating the global burden of fungal diseases and antifungal resistance (AFR), as well as limited surveillance capabilities and lack of routine AFR testing. Furthermore, training programs should incorporate sufficient information on fungal diseases, necessitating global advocacy to educate health care professionals and scientists. Established international guidelines and the FPPL are vital in strengthening local guidance on tackling fungal diseases. Future iterations of the FPPL have the potential to refine the list further, addressing its limitations and advancing our collective ability to combat fungal diseases effectively. Napp Pharmaceuticals Limited (Mundipharma UK) organized a workshop with key experts from Northern Europe to discuss the impact of the FPPL on regional clinical practice.<\/jats:p>","DOI":"10.1093\/ofid\/ofae372","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T21:21:01Z","timestamp":1719868861000},"source":"Crossref","is-referenced-by-count":13,"title":["The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective"],"prefix":"10.1093","volume":"11","author":[{"given":"Maiken Cavling","family":"Arendrup","sequence":"first","affiliation":[{"name":"Unit of Mycology, Statens Serum Institut , Copenhagen , Denmark"},{"name":"Department of Clinical Microbiology, Rigshospitalet , Copenhagen , Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Armstrong-James","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M","family":"Borman","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory, UK Health Security Agency , Bristol , UK"},{"name":"Medical Research Council Centre for Medical Mycology, University of Exeter , Exeter , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Denning","sequence":"additional","affiliation":[{"name":"Manchester Fungal Infection Group, The University of Manchester , Manchester , UK"},{"name":"Global Action For Fungal Infections , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-6402","authenticated-orcid":false,"given":"Matthew C","family":"Fisher","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Imperial College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gorton","sequence":"additional","affiliation":[{"name":"Department of Infection Sciences, Health Services Laboratories , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Gasthuisberg , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, St. James's Hospital , Dublin , Ireland"},{"name":"Hospital Clinic, IDIBAPS, Universidad de Barcelona , Spain"},{"name":"CIBERes , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-0971","authenticated-orcid":false,"given":"Varun","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Haematological Medicine, Kings College Hospital NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine","family":"Mercier","sequence":"additional","affiliation":[{"name":"Department of Oncology-Hematology, AZ Sint-Maarten , Mechelen , Belgium"},{"name":"Department of Microbiology, Immunology, and Transplantation, KU Leuven , Leuven , Belgium"},{"name":"Department of Hematology, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Price","sequence":"additional","affiliation":[{"name":"Public Health Wales Mycology Reference Laboratory, UHW , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-6040","authenticated-orcid":false,"given":"Riina","family":"Rautemaa-Richardson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Manchester University NHS Foundation Trust, Wythenshawe Hospital , Manchester , UK"},{"name":"Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, NIHR Manchester Biomedical Research Centre (BRC) at the Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Wythenshawe Hospital , Manchester , UK"},{"name":"Mycology Reference Centre Manchester (MRCM), ECMM Excellence Centre of Medical Mycology, Manchester University NHS Foundation Trust, Wythenshawe Hospital , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Wake","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, St George's University of London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Andrews","sequence":"additional","affiliation":[{"name":"Napp Pharmaceuticals Limited, a member of the Mundipharma network of independent associated companies, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3056-4205","authenticated-orcid":false,"given":"P Lewis","family":"White","sequence":"additional","affiliation":[{"name":"Public Health Wales Mycology Reference Laboratory, UHW , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"2024072916083321700_ofae372-B1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"issue":":","key":"2024072916083321700_ofae372-B2","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2024072916083321700_ofae372-B3","doi-asserted-by":"crossref","first-page":"20160332","DOI":"10.1098\/rstb.2016.0332","article-title":"Tackling emerging fungal threats to animal health, food security and ecosystem resilience","volume":"371","author":"Fisher","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2024072916083321700_ofae372-B4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/microorganisms10061208","article-title":"Continuing shifts in epidemiology and antifungal susceptibility highlight the need for improved disease management of invasive candidiasis","volume":"10","author":"Parslow","year":"2022","journal-title":"Microorganisms"},{"key":"2024072916083321700_ofae372-B5","doi-asserted-by":"crossref","first-page":"e939088","DOI":"10.12659\/MSM.939088","article-title":"Editorial: the World Health Organization (WHO) fungal priority pathogens list in response to emerging fungal pathogens during the COVID-19 pandemic","volume":"28","author":"Parums","year":"2022","journal-title":"Med Sci Monit"},{"key":"2024072916083321700_ofae372-B6","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"2024072916083321700_ofae372-B7","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024072916083321700_ofae372-B8","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"2024072916083321700_ofae372-B9","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/S1473-3099(17)30443-7","article-title":"Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks","volume":"17","author":"Benedict","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2024072916083321700_ofae372-B10","doi-asserted-by":"crossref","first-page":"e13706","DOI":"10.1111\/myc.13706","article-title":"Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: description of azole-resistance profiles associated with the Y132F ERG11p substitution","volume":"67","author":"Mesquida","year":"2024","journal-title":"Mycoses"},{"key":"2024072916083321700_ofae372-B11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jinf.2019.09.007","article-title":"Candida auris outbreak: mortality, interventions and cost of sustaining control","volume":"79","author":"Taori","year":"2019","journal-title":"J Infect"},{"key":"2024072916083321700_ofae372-B12","author":"World Health Organization","year":"2022"},{"key":"2024072916083321700_ofae372-B13","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3201\/eid2907.230025","article-title":"Sexually transmitted Trichophyton mentagrophytes genotype VII infection among men who have sex with men","volume":"29","author":"Jabet","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2024072916083321700_ofae372-B14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/jof7110983","article-title":"Antifungal resistance in dermatophytes: genetic considerations, clinical presentations and alternative therapies","volume":"7","author":"Sacheli","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3389\/fmicb.2015.01322","article-title":"Optimizing outcomes in immunocompromised hosts: understanding the role of immunotherapy in invasive fungal diseases","volume":"6","author":"Ravikumar","year":"2015","journal-title":"Front Microbiol"},{"key":"2024072916083321700_ofae372-B16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3201\/eid2003.131230","article-title":"Invasive fungal infections after natural disasters","volume":"20","author":"Benedict","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2024072916083321700_ofae372-B17","doi-asserted-by":"crossref","first-page":"e200430","DOI":"10.1590\/0074-02760200430","article-title":"Invasive fungal disease in humans: are we aware of the real impact?","volume":"115","author":"Firacative","year":"2020","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":":","key":"2024072916083321700_ofae372-B18","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2666-5247(24)00039-9","article-title":"Impact of climate change and natural disasters on fungal infections","volume":"5","author":"Seidel","year":"2024","journal-title":"Lancet Microbe"},{"key":"2024072916083321700_ofae372-B19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/jof9080820","article-title":"Public health research priorities for fungal diseases: a multidisciplinary approach to save lives","volume":"9","author":"Smith","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B20","doi-asserted-by":"crossref","first-page":"e01397","DOI":"10.1128\/mBio.01397-19","article-title":"On the emergence of Candida auris: climate change, azoles, swamps, and birds","volume":"10","author":"Casadevall","year":"2019","journal-title":"mBio"},{"key":"2024072916083321700_ofae372-B21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"2024072916083321700_ofae372-B22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","article-title":"European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study","volume":"87","author":"Arendrup","year":"2023","journal-title":"J Infect"},{"key":"2024072916083321700_ofae372-B23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/pathogens12111305","article-title":"Drug-resistant Aspergillus spp.: a literature review of its resistance mechanisms and its prevalence in Europe","volume":"12","author":"De Francesco","year":"2023","journal-title":"Pathogens"},{"key":"2024072916083321700_ofae372-B24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-023-00861-x","article-title":"The WHO fungal priority pathogens list as a game-changer","volume":"21","author":"Fisher","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2024072916083321700_ofae372-B25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bmb\/ldad011","article-title":"The SSS revolution in fungal diagnostics: speed, simplicity and sensitivity","volume":"147","author":"Baker","year":"2023","journal-title":"Br Med Bull"},{"key":"2024072916083321700_ofae372-B26","volume-title":"Second WHO Model List of Essential in Vitro Diagnostics","author":"World Health Organization","year":"2019"},{"key":"2024072916083321700_ofae372-B27","volume-title":"The Selection and Use of Essential In Vitro Diagnostics","author":"World Health Organization Technical Report Series","year":"2020"},{"key":"2024072916083321700_ofae372-B28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/myc.12890","article-title":"Clinical mycology in Latin America and the Caribbean: a snapshot of diagnostic and therapeutic capabilities","volume":"62","author":"Falci","year":"2019","journal-title":"Mycoses"},{"key":"2024072916083321700_ofae372-B29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jtos.2023.08.010","article-title":"Diagnostic capacity for fungal keratitis in Africa\u2014survey in 50 African countries","volume":"30","author":"Makangara Cigolo","year":"2023","journal-title":"Ocul Surf"},{"key":"2024072916083321700_ofae372-B30","article-title":"Point of care tests for invasive fungal infections: a blueprint for increasing availability in Africa","volume":"8","author":"Osaigbovo","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"2024072916083321700_ofae372-B31","doi-asserted-by":"crossref","first-page":"106718","DOI":"10.1016\/j.ijantimicag.2023.106718","article-title":"The current state of laboratory mycology in Asia\/Pacific: a survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)","volume":"61","author":"Salmanton-Garcia","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2024072916083321700_ofae372-B32","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2666-5247(22)00261-0","article-title":"The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey","volume":"4","author":"Salmanton-Garcia","year":"2023","journal-title":"Lancet Microbe"},{"key":"2024072916083321700_ofae372-B33","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jiph.2023.08.015","article-title":"Access to the World Health Organization-recommended essential diagnostics for invasive fungal infections in critical care and cancer patients in Africa: a diagnostic survey","volume":"16","author":"Tufa","year":"2023","journal-title":"J Infect Public Health"},{"key":"2024072916083321700_ofae372-B34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/myc.13585","article-title":"Fungal infections in Algeria","volume":"66","author":"Aissat","year":"2023","journal-title":"Mycoses"},{"key":"2024072916083321700_ofae372-B35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/INF.0000000000002983","article-title":"Global divergence of antifungal prescribing patterns: data from the global antimicrobial resistance, prescribing, and efficacy in neonates and children surveys","volume":"40","author":"Ferreras-Antolin","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2024072916083321700_ofae372-B36","doi-asserted-by":"crossref","first-page":"00397","DOI":"10.1183\/23120541.00397-2022","article-title":"Diagnostic options for pulmonary fungal diseases in Africa","volume":"9","author":"Mushi","year":"2023","journal-title":"ERJ Open Res"},{"key":"2024072916083321700_ofae372-B37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/myc.13044","article-title":"Bridging the knowledge gap on mycoses in Africa: setting up a pan-African mycology working group","volume":"63","author":"Oladele","year":"2020","journal-title":"Mycoses"},{"key":"2024072916083321700_ofae372-B38","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1016\/S1473-3099(17)30308-0","article-title":"Improvement of fungal disease identification and management: combined health systems and public health approaches","volume":"17","author":"Cole","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2024072916083321700_ofae372-B39","doi-asserted-by":"crossref","first-page":"XXX\u2013XX","DOI":"10.1093\/ofid\/ofac277","article-title":"Cryptococcal and histoplasma antigen screening among people with human immunodeficiency virus in Ghana and comparative analysis of OIDx histoplasma lateral flow assay and IMMY histoplasma enzyme immunoassay","volume":"9","author":"Ocansey","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024072916083321700_ofae372-B40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof9010026","article-title":"Importance of Aspergillus-specific antibody screening for diagnosis of chronic pulmonary aspergillosis after tuberculosis treatment: a prospective follow-up study in Ghana","volume":"9","author":"Ocansey","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4269\/ajtmh.15-0083","article-title":"Cost-effectiveness of surveillance for bloodstream infections for sepsis management in low-resource settings","volume":"93","author":"Penno","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"2024072916083321700_ofae372-B42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/thoraxjnl-2015-207305","article-title":"The ambitious \u201895-95 by 2025' roadmap for the diagnosis and management of fungal diseases","volume":"70","author":"Denning","year":"2015","journal-title":"Thorax"},{"key":"2024072916083321700_ofae372-B43","doi-asserted-by":"crossref","first-page":"myac081","DOI":"10.1093\/mmy\/myac081","article-title":"The importance of appropriate processing and direct microscopic examination for the timely diagnosis and management of invasive infections caused by filamentous fungi","volume":"60","author":"Borman","year":"2022","journal-title":"Med Mycol"},{"key":"2024072916083321700_ofae372-B44","doi-asserted-by":"crossref","first-page":"a019299","DOI":"10.1101\/cshperspect.a019299","article-title":"Fungal diagnostics","volume":"4","author":"Kozel","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2024072916083321700_ofae372-B45","doi-asserted-by":"crossref","first-page":"e0178420","DOI":"10.1128\/JCM.01784-20","article-title":"Recognition of diagnostic gaps for laboratory diagnosis of fungal diseases: expert opinion from the Fungal Diagnostics Laboratories Consortium (FDLC)","volume":"59","author":"Zhang","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2024072916083321700_ofae372-B46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00091-13","article-title":"Molecular and nonmolecular diagnostic methods for invasive fungal infections","volume":"27","author":"Arvanitis","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2024072916083321700_ofae372-B47","article-title":"Case of undiagnosed Pneumocystis pneumonia (PCP)","volume":"2017","author":"Arshad","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2024072916083321700_ofae372-B48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/myc.12836","article-title":"Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: new leadership is about working together","volume":"61","author":"Hoenigl","year":"2018","journal-title":"Mycoses"},{"key":"2024072916083321700_ofae372-B49","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S1473-3099(21)00191-2","article-title":"Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology","volume":"21","author":"Thompson","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024072916083321700_ofae372-B50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","article-title":"Diagnosis of invasive fungal infections: challenges and recent developments","volume":"30","author":"Fang","year":"2023","journal-title":"J Biomed Sci"},{"key":"2024072916083321700_ofae372-B51","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/cis132","article-title":"Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections","volume":"54","author":"Kourkoumpetis","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2024072916083321700_ofae372-B52","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cmi.2023.05.012","article-title":"How to use direct microscopy for diagnosing fungal infections","volume":"29","author":"Knoll","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2024072916083321700_ofae372-B53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/jof6040349","article-title":"Biosensors and diagnostics for fungal detection","volume":"6","author":"Kussain","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B54","doi-asserted-by":"crossref","first-page":"XXX\u2013XX","DOI":"10.1093\/ofid\/ofab471","article-title":"Trends of the epidemiology of candidemia in Switzerland: a 15-year FUNGINOS survey","volume":"8","author":"Adam","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2024072916083321700_ofae372-B55","doi-asserted-by":"crossref","first-page":"e0005638","DOI":"10.1371\/journal.pntd.0005638","article-title":"Mycetoma laboratory diagnosis: review article","volume":"11","author":"Ahmed","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2024072916083321700_ofae372-B56","first-page":"3720549","article-title":"Detection of the dimorphic phases of Mucor circinelloides in blood cultures from an immunosuppressed female","volume":"2016","author":"Arroyo","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"2024072916083321700_ofae372-B57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.29245\/2578-3009\/2018\/5.1137","article-title":"A review of a diagnostic tool: galactomannan","volume":"2","author":"Avcu","year":"2018","journal-title":"J Immunol Sci"},{"key":"2024072916083321700_ofae372-B58","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/JCM.02430-16","article-title":"Laboratory diagnostics for histoplasmosis","volume":"55","author":"Azar","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2024072916083321700_ofae372-B59","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/mmy\/myaa024","article-title":"Diagnosing Pneumocystis jirovecii pneumonia: a review of current methods and novel approaches","volume":"58","author":"Bateman","year":"2020","journal-title":"Med Mycol"},{"key":"2024072916083321700_ofae372-B60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/jof8040343","article-title":"Fungal infections of implantation: more than five years of cases of subcutaneous fungal infections seen at the UK mycology reference laboratory","volume":"8","author":"Borman","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B61","doi-asserted-by":"crossref","first-page":"e15021","DOI":"10.1097\/MD.0000000000015021","article-title":"Evaluation of Aspergillus IgG, IgM antibody for diagnosing in chronic pulmonary aspergillosis: a prospective study from a single center in China","volume":"98","author":"Guo","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2024072916083321700_ofae372-B62","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/microorganisms10071317","article-title":"Lomentospora prolificans: an emerging opportunistic fungal pathogen","volume":"10","author":"Konsoula","year":"2022","journal-title":"Microorganisms"},{"key":"2024072916083321700_ofae372-B63","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/microorganisms9071518","article-title":"Microbiological and molecular diagnosis of mucormycosis: from old to new","volume":"9","author":"Lackner","year":"2021","journal-title":"Microorganisms"},{"key":"2024072916083321700_ofae372-B64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jof2030022","article-title":"Galactomannan and 1,3-beta-d-glucan testing for the diagnosis of invasive aspergillosis","volume":"2","author":"Lamoth","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2024072916083321700_ofae372-B66","doi-asserted-by":"crossref","first-page":"e0158122","DOI":"10.1128\/jcm.01581-22","article-title":"Review of clinical and laboratory diagnostics for coccidioidomycosis","volume":"61","author":"McHardy","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2024072916083321700_ofae372-B67","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1590\/s1678-9946202062025","article-title":"Performance of a new Candida anti-mannan IgM and IgG assays in the diagnosis of candidemia","volume":"62","author":"Meng","year":"2020","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"Suppl 2","key":"2024072916083321700_ofae372-B68","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","article-title":"Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases","volume":"72","author":"Mercier","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024072916083321700_ofae372-B69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/jof5040113","article-title":"Serial detection of circulating Mucorales DNA in invasive mucormycosis: a retrospective multicenter evaluation","volume":"5","author":"Mercier","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B70","first-page":"402","article-title":"Determining the analytical specificity of PCR-based assays for the diagnosis of IA: what is Aspergillus?","volume":"55","author":"Morton","year":"2017","journal-title":"Med Mycol"},{"key":"2024072916083321700_ofae372-B71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/jof8030281","article-title":"Novel chromogenic medium CHROMagar(TM) Candida plus for detection of Candida auris and other Candida species from surveillance and environmental samples: a multicenter study","volume":"8","author":"Mulet Bayona","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12281-016-0256-3","article-title":"Evolution of cryptococcal antigen testing: what is new?","volume":"10","author":"Nalintya","year":"2016","journal-title":"Curr Fungal Infect Rep"},{"key":"2024072916083321700_ofae372-B73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/jof6040293","article-title":"Molecular tools for detection and identification of Paracoccidioides species: current status and future perspectives","volume":"6","author":"Pinheiro","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/abd1806-4841.20187075","article-title":"Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review","volume":"93","author":"Reis","year":"2018","journal-title":"An Bras Dermatol"},{"key":"2024072916083321700_ofae372-B75","doi-asserted-by":"crossref","first-page":"e01487-19","DOI":"10.1128\/JCM.01487-19","article-title":"Updates in laboratory diagnostics for invasive fungal infections","volume":"58","author":"Terrero-Salcedo","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2024072916083321700_ofae372-B76","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/jof9060647","article-title":"An overview of diagnostic and management strategies for talaromycosis, an underrated disease","volume":"9","author":"Zaongo","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B77","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/JCM.01737-13","article-title":"Beta-D-glucan testing is important for diagnosis of invasive fungal infections","volume":"51","author":"Theel","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2024072916083321700_ofae372-B78","first-page":"CD009833","article-title":"(1\u2013&gt;3)-beta-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people","volume":"7","author":"White","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2024072916083321700_ofae372-B79","doi-asserted-by":"crossref","first-page":"e43347","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS One"},{"key":"2024072916083321700_ofae372-B80","doi-asserted-by":"crossref","first-page":"XXX\u2013XX","DOI":"10.1093\/ofid\/ofac234","article-title":"The role of diagnostics-driven antifungal stewardship in the management of invasive fungal infections: a systematic literature review","volume":"9","author":"Chakrabarti","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024072916083321700_ofae372-B81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12281-016-0254-5","article-title":"Point of care testing for the diagnosis of fungal infections: are we there yet?","volume":"10","author":"Prattes","year":"2016","journal-title":"Curr Fungal Infect Rep"},{"key":"2024072916083321700_ofae372-B82","doi-asserted-by":"crossref","first-page":"myac059","DOI":"10.1093\/mmy\/myac059","article-title":"Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review","volume":"60","author":"Amona","year":"2022","journal-title":"Med Mycol"},{"key":"2024072916083321700_ofae372-B83","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2666-5247(23)00003-4","article-title":"WHO publish fungal priority pathogens list","volume":"4","author":"Burki","year":"2023","journal-title":"Lancet Microbe"},{"key":"2024072916083321700_ofae372-B84","doi-asserted-by":"crossref","first-page":"e1009711","DOI":"10.1371\/journal.ppat.1009711","article-title":"Azole-resistant Aspergillus fumigatus in the environment: identifying key reservoirs and hotspots of antifungal resistance","volume":"17","author":"Burks","year":"2021","journal-title":"PLoS Pathog"},{"key":"2024072916083321700_ofae372-B85","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","article-title":"Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap","volume":"4","author":"Daneshnia","year":"2023","journal-title":"Lancet Microbe"},{"key":"2024072916083321700_ofae372-B86","doi-asserted-by":"crossref","first-page":"1010782","DOI":"10.3389\/ffunb.2022.1010782","article-title":"Fluconazole-resistant Candida parapsilosis: a new emerging threat in the fungi arena","volume":"3","author":"Escribano","year":"2022","journal-title":"Front Fungal Biol"},{"key":"2024072916083321700_ofae372-B87","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fmicb.2017.00464","article-title":"Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): molecular epidemiology and clinical azole consumption","volume":"8","author":"Fan","year":"2017","journal-title":"Front Microbiol"},{"key":"2024072916083321700_ofae372-B88","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cmi.2018.11.007","article-title":"Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China","volume":"25","author":"Fan","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2024072916083321700_ofae372-B89","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2024072916083321700_ofae372-B90","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/tropicalmed7080188","article-title":"Global prevalence of antifungal-resistant Candida parapsilosis: a systematic review and meta-analysis","volume":"7","author":"Yamin","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"2024072916083321700_ofae372-B91","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/jof8070757","article-title":"Trichophyton indotineae-an emerging pathogen causing recalcitrant dermatophytoses in India and worldwide\u2014a multidimensional perspective","volume":"8","author":"Uhrlass","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B92","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/jof8020150","article-title":"Increasing terbinafine resistance in Danish Trichophyton isolates 2019\u20132020","volume":"8","author":"Astvad","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11046-023-00720-6","article-title":"Insights into changing dermatophyte spectrum in India through analysis of cumulative 161,245 cases between 1939 and 2021","volume":"188","author":"Kumar","year":"2023","journal-title":"Mycopathologia"},{"key":"2024072916083321700_ofae372-B94","doi-asserted-by":"crossref","first-page":"e0056223","DOI":"10.1128\/jcm.00562-23","article-title":"Terbinafine-resistant dermatophytes and the presence of Trichophyton indotineae in North America","volume":"61","author":"Canete-Gibas","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2024072916083321700_ofae372-B95","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.02566-12","article-title":"Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011","volume":"51","author":"Asmundsdottir","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2024072916083321700_ofae372-B96","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/23744235.2019.1595709","article-title":"The impact of age on risk assessment, therapeutic practice and outcome in candidemia","volume":"51","author":"Hesstvedt","year":"2019","journal-title":"Infect Dis (Lond)"},{"key":"2024072916083321700_ofae372-B97","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fmicb.2016.00915","article-title":"A prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients","volume":"7","author":"Rajendran","year":"2016","journal-title":"Front Microbiol"},{"key":"2024072916083321700_ofae372-B98","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/jof7060491","article-title":"Update 2016\u20132018 of the nationwide Danish Fungaemia Surveillance Study: epidemiologic changes in a 15-year perspective","volume":"7","author":"Risum","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B99","doi-asserted-by":"crossref","first-page":"1170.e1","DOI":"10.1016\/j.cmi.2020.09.042","article-title":"Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain","volume":"27","author":"Escribano","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024072916083321700_ofae372-B100","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid2607.200088","article-title":"Paradoxal trends in azole-resistant Aspergillus fumigatus in a national multicenter surveillance program, The Netherlands, 2013\u20132018","volume":"26","author":"Lestrade","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2024072916083321700_ofae372-B101","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/myc.13426","article-title":"Azole resistance in Aspergillus fumigatus. The first 2-year's data from the Danish National Surveillance Study, 2018\u20132020","volume":"65","author":"Risum","year":"2022","journal-title":"Mycoses"},{"key":"2024072916083321700_ofae372-B102","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/jac\/dkaa316","article-title":"Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46\/Y121F\/T289A cyp51A mutation","volume":"75","author":"Siopi","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2024072916083321700_ofae372-B103","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00233-15","article-title":"Nationwide surveillance of azole resistance in Aspergillus diseases","volume":"59","author":"Vermeulen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2024072916083321700_ofae372-B104","author":"English Surveillance Programme for Antimicrobial Utilisation And Resistance (ESPAUR)"},{"key":"2024072916083321700_ofae372-B105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/14787210.2023.2227790","article-title":"Will invasive fungal infections be the last of US? The importance of surveillance, public-health interventions, and antifungal stewardship","volume":"21","author":"Rodriguez Stewart","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2024072916083321700_ofae372-B106","doi-asserted-by":"crossref","first-page":"e00069","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal susceptibility testing: current approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"2024072916083321700_ofae372-B107","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/jof8020141","article-title":"A pragmatic approach to susceptibility classification of yeasts without EUCAST clinical breakpoints","volume":"8","author":"Astvad","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2024072916083321700_ofae372-B109","first-page":"43","article-title":"Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris","volume":"7","author":"Rhodes","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"2024072916083321700_ofae372-B110","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1042\/BST20211123","article-title":"Using genomics to understand the mechanisms of virulence and drug resistance in fungal pathogens","volume":"50","author":"Schikora-Tamarit","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"2024072916083321700_ofae372-B111","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/jof8030249","article-title":"Surveillance of antifungal resistance in candidemia fails to inform antifungal stewardship in European countries","volume":"8","author":"Galia","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/mmy.38.s1.33.40","article-title":"Training medical myocologists in developing countries","volume":"38","author":"Evans","year":"2000","journal-title":"Med Mycol"},{"key":"2024072916083321700_ofae372-B113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2020.02.027","article-title":"Diagnosis and management of fungal infections: improvement in medical training and investment in new technologies and treatments","volume":"94","author":"Garcia-Lechuz","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2024072916083321700_ofae372-B114","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/IDR.S390946","article-title":"Management of bacterial and fungal infections in the ICU: diagnosis, treatment, and prevention recommendations","volume":"16","author":"Rawson","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2024072916083321700_ofae372-B115","doi-asserted-by":"crossref","first-page":"e0011136","DOI":"10.1371\/journal.pntd.0011136","article-title":"Recognition of fungal priority pathogens: what next?","volume":"17","author":"Rodrigues","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"2024072916083321700_ofae372-B116","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1016\/B978-0-12-386456-7.06304-8","article-title":"Microbiology in clinical pathology","author":"Frank","year":"2014","journal-title":"Pathobiol Hum Dis"},{"key":"2024072916083321700_ofae372-B117","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-018-07556-5","article-title":"Molecular diagnostics in medical mycology","volume":"9","author":"Wickes","year":"2018","journal-title":"Nat Commun"},{"key":"2024072916083321700_ofae372-B118","doi-asserted-by":"crossref","first-page":"jkac224","DOI":"10.1093\/g3journal\/jkac224","article-title":"The future of fungi: threats and opportunities","volume":"12","author":"Case","year":"2022","journal-title":"G3 (Bethesda)"},{"key":"2024072916083321700_ofae372-B119","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jof7010041","article-title":"Recent advances and novel approaches in laboratory-based diagnostic mycology","volume":"7","author":"White","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B120","doi-asserted-by":"crossref","first-page":"e0007964","DOI":"10.1371\/journal.pntd.0007964","article-title":"Fungal diseases as neglected pathogens: a wake-up call to public health officials","volume":"14","author":"Rodrigues","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2024072916083321700_ofae372-B121","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in Cooperation With the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2024072916083321700_ofae372-B122","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/iwj.12630","article-title":"Candida albicans colonisation, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study","volume":"14","author":"Campbell","year":"2017","journal-title":"Int Wound J"},{"key":"2024072916083321700_ofae372-B123","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024072916083321700_ofae372-B124","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024072916083321700_ofae372-B125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2024072916083321700_ofae372-B126","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12281-023-00465-1","article-title":"Antifungal stewardship interventions in patients with hematologic malignancies","volume":"17","author":"Vergidis","year":"2023","journal-title":"Curr Fungal Infect Rep"},{"key":"2024072916083321700_ofae372-B127","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jac\/dkac378","article-title":"EQUAL CPA score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis","volume":"78","author":"Sprute","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2024072916083321700_ofae372-B128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(22)00872-6","article-title":"Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study","volume":"23","author":"Hoenigl","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2024072916083321700_ofae372-B129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/jof8030258","article-title":"A clustered case series of Mucorales detection in respiratory samples from COVID-19 patients in intensive care, France, August to September 2021","volume":"8","author":"Guemas","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024072916083321700_ofae372-B130","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3201\/eid1810.120068","article-title":"Autochthonous and dormant Cryptococcus gattii infections in Europe","volume":"18","author":"Hagen","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2024072916083321700_ofae372-B131","author":"Algorri","year":"2019"},{"key":"2024072916083321700_ofae372-B132","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12281-014-0205-y","article-title":"Combat-related invasive fungal wound infections","volume":"8","author":"Tribble","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"2024072916083321700_ofae372-B133","volume-title":"WHO Guidelines for Indoor Air Quality: Dampness and Mould","author":"World Health Organization","year":"2009"},{"key":"2024072916083321700_ofae372-B134","doi-asserted-by":"crossref","first-page":"102325","DOI":"10.1016\/j.eclinm.2023.102325","article-title":"Social determinants of health as drivers of fungal disease","volume":"66","author":"Jenks","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2024072916083321700_ofae372-B135","doi-asserted-by":"crossref","first-page":"2002554","DOI":"10.1183\/13993003.02554-2020","article-title":"Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis","volume":"56","author":"Armstrong-James","year":"2020","journal-title":"Eur Respir J"},{"key":"2024072916083321700_ofae372-B136","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/ijmr.IJMR_768_21","article-title":"One Health aspects & priority roadmap for fungal diseases: a mini-review","volume":"153","author":"Banerjee","year":"2021","journal-title":"Indian J Med Res"},{"key":"2024072916083321700_ofae372-B137","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.fbr.2020.10.003","article-title":"The One Health problem of azole resistance in Aspergillus fumigatus: current insights and future research agenda","volume":"34","author":"Verweij","year":"2020","journal-title":"Fungal Biol Rev"},{"key":"2024072916083321700_ofae372-B138","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41564-023-01542-4","article-title":"Aspergillus fumigatus strains that evolve resistance to the agrochemical fungicide ipflufenoquin in vitro are also resistant to olorofim","volume":"9","author":"van Rhijn","year":"2024","journal-title":"Nat Microbiol"},{"key":"2024072916083321700_ofae372-B139","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-022-01091-2","article-title":"Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment","volume":"7","author":"Rhodes","year":"2022","journal-title":"Nat Microbiol"},{"key":"2024072916083321700_ofae372-B140","doi-asserted-by":"crossref","first-page":"eadh8839","DOI":"10.1126\/sciadv.adh8839","article-title":"Citizen science reveals landscape-scale exposures to multiazole-resistant Aspergillus fumigatus bioaerosols","volume":"9","author":"Shelton","year":"2023","journal-title":"Sci Adv"},{"key":"2024072916083321700_ofae372-B141","doi-asserted-by":"crossref","first-page":"743","DOI":"10.14202\/vetworld.2022.743-749","article-title":"Antimicrobial resistance: One Health approach","volume":"15","author":"Velazquez-Meza","year":"2022","journal-title":"Vet World"},{"key":"2024072916083321700_ofae372-B142","doi-asserted-by":"crossref","first-page":"fuab058","DOI":"10.1093\/femsre\/fuab058","article-title":"Fungi as mediators linking organisms and ecosystems","volume":"46","author":"Bahram","year":"2022","journal-title":"FEMS Microbiol Rev"},{"key":"2024072916083321700_ofae372-B143","doi-asserted-by":"crossref","first-page":"5313691","DOI":"10.1155\/2017\/5313691","article-title":"Paracoccidioides spp.: virulence factors and immune-evasion strategies","volume":"2017","author":"Camacho","year":"2017","journal-title":"Mediators Inflamm"},{"key":"2024072916083321700_ofae372-B144","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jof5030055","article-title":"Invasive aspergillosis by Aspergillus flavus: epidemiology, diagnosis, antifungal resistance, and management","volume":"5","author":"Rudramurthy","year":"2019","journal-title":"J Fungi (Basel)"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae372\/58437586\/ofae372.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/7\/ofae372\/58650272\/ofae372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/7\/ofae372\/58650272\/ofae372.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:08:11Z","timestamp":1722298091000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae372\/7702399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":144,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae372","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,28]]},"article-number":"ofae372"}}